Xu Zhou is Research assistant in pharmacology and toxicology, University of Arizona, Tucson, AZ. She received M.D. from Tianjin Medical University, Tianjin, China in 2009 and M.S. from China Medical University in 2012. After that, she moved to USA for working as a research technician for two years, and continued to pursue Ph.D. in pharmacology and toxicology, University of Arizona, Tucson, AZ. Since 2012 Xu Zhou has published several papers focusing on pulmonary related diseases and ocular related diseases. Her latest research project is about the infectious lung diseases. She is also some members of the Editorial Board of some journals.
Xu Zhou’s research interests are include, but not limited to, developing drugs used for the treatment of virus-induced asthma exacerbation, as well as drugs blocking airway epithelium differentiation and mucous cell metaplasia in chronic airway diseases. Xu’s latest research focuses on discovering the specific molecular mechanism of the diseases in both in vitro and in vivo research systems, and further developing drugs based on the identified molecular targets. Beside new drug development, Xu is also interested in exploring less toxic drug delivery methods to treat lung diseases, as well as other supplementary technologies and application in pharmacology and toxicology.